D
Dycare
AI-powered telerehabilitation for musculoskeletal and neurological conditions
About Dycare
Dycare, founded in 2015 by Silvia Raga and Ricardo Jauregui, develops portable medical devices and digital solutions to enhance the rehabilitation process for patients with musculoskeletal and neurological issues. The company is headquartered in Barcelona, Spain.
Read full description
The firm's core product is ReHub, a B2B telerehabilitation platform that enables physiotherapists and hospitals to offer remote, personalized therapy. ReHub utilizes computer vision and AI to guide patients through exercises, tracking movement, speed, and repetitions via the user's mobile camera to ensure correct execution. The platform provides objective, real-time measurements of muscle strength and joint movement, allowing for detailed monitoring of patient progress through intuitive dashboards and reports. This approach is designed to increase patient adherence and accelerate recovery times.
Dycare's business model is primarily B2B, serving clients such as hospitals, physical therapy clinics, insurance companies, and corporations. Clients like DKV, Vall d'Hebron Hospital, and Hospital Clínic use the platform to complement in-person treatments, improve service quality, and manage operations more efficiently. For corporations, Dycare offers a Wellness API to provide employees with personalized exercise programs aimed at preventing musculoskeletal discomfort and improving overall health and productivity. Revenue is generated by offering these digital solutions to their client base.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Barcelona, Spain
- Employees
- 34
- Open positions
- None listed
- Dealroom signal
- 82.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Rehabilitation, Biotechnology, Physiotherapy
- Technology
- Hardware, Deep Tech, Connected Device, Recognition Technology, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Dycare.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SUPPORT PROGRAM✓Other financing | Jan 2025 | $0 | — | EIT Health | — |
| SEED✓Equity / VC | Feb 2022 | $1.4M | $5.7M | Board Advisors Deutschland AG · Viopas Venture Consulting | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Dycare is 6.5K monthly website visits, up 41.3% over the last three months. Dycare's team grew 13.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
European Innovation Council
Sanitas Disruptive
Board Advisors Deutschland AG
Viopas Venture Consulting
Other known investors1 additional known investor
EIT Health
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dycare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dycare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.